XETR
SRT3
Market cap15bUSD
Sep 17, Last price
248.30EUR
1D
2.43%
1Q
16.57%
Jan 2017
246.88%
Name
Sartorius AG
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sartorius AG, a German company established in 1870 and based in Göttingen, is a global supplier of innovative bioprocess solutions and laboratory products and services. The company's extensive portfolio supports life science research, biopharmaceutical manufacturing, quality control, and other applied industries worldwide. Its offerings encompass a wide array of sophisticated tools and consumables, including: Advanced Analytics: Biosensors, label-free detection, and SPR systems; live-cell analysis platforms, flow cytometry, and related reagents. Cell Culture and Fermentation: Various bioreactors (e.g., single-use, stainless steel, benchtop) along with specialized media (for antibodies, recombinant proteins, stem cells, viral vaccines) and other essential reagents like buffers and microcarriers. Filtration and Separation: A comprehensive range of membranes, filter papers, syringe filters, and diverse filtration and ultrafiltration devices for sterile processing, sample preparation, and clarification. Laboratory Essentials: Weighing and pipetting systems, centrifuges, industrial microbiology systems, and water purification units. Process Solutions: Fluid management, process chromatography, and advanced analytical technologies coupled with data analytics. Beyond products, Sartorius provides crucial support services such as bioprocess development and engineering, protein expression system services, media and process optimization, testing, instrument services, and validation assistance.
Related entities
Subsidiaries (8)
SARTORIUS INDIA PRIVATE LIMITED
Sartorius Lab Holding GmbH
Sartorius Lab Instruments GmbH & Co. KG
Sartorius Stedim FMT SAS
SARTORIUS STEDIM INDIA PRIVATE LIMITED
Sartorius Weighing Technology GmbH
Sartorius Stedim Biotech GmbH
Key people
Manfred Zaffke
Independent Vice Chairman of the Supervisory Board, Employee Representative · since 2014
Rene Faber
Member of the Executive Board, Head of the Bioprocess Solutions Division · since 2019
Uwe Bretthauer
Independent Member of the Supervisory Board, Employee Representative
Michael Dohrmann
Independent Member of the Supervisory Board, Employee Representative · since 2006
Daniela Favoccia
Independent Member of the Supervisory Board · since 2017
Karoline Kleinschmidt
Independent Member of the Supervisory Board, Employee Representative · since 2012
Petra Kirchhoff
Independent Member of the Supervisory Board · since 2010
Thomas Scheper
Independent Member of the Supervisory Board · since 2012
Legal address
Otto-Brenner-Straße 20
Göttingen, NI 37079
DE
Göttingen, NI 37079
DE
Headquarters
Weender Landstraße 94-108
Göttingen, NI 37075
DE
Göttingen, NI 37075
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||